This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cornicelli, J. A. Articles by Daugherty, A. Search for Related Content PubMed PubMed Citation Articles by Cornicelli, J. A. Articles by Daugherty, A. Pubmed/NCBI databases Substance via MeSH

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1488-1494.)
© 1996 American Heart Association, Inc.

Articles

Mouse Peritoneal Macrophages Contain Abundant -6 Lipoxygenase Activity That Is Independent of Interleukin-4

Joseph A. Cornicelli; Kathryn Welch; Bruce Auerbach; Steven J. Feinmark; Alan Daugherty

the Department of Atherosclerosis Therapeutics (J.A.C., K.W., B.A.), Parke-Davis Pharmaceutical Research Division, Warner Lambert Co, Ann Arbor, MI; the Department of Pharmacology (S.J.F.), College of Physicians and Surgeons, Columbia University, New York, NY; and the Cardiovascular Division (A.D.), Department of Medicine, Washington University School of Medicine, St. Louis, Mo.

Correspondence to Joseph A. Cornicelli, PhD, Department of Vascular and Cardiac Disease, Parke-Davis Pharmaceutical Research, 2800 Plymouth Rd, Ann Arbor, MI 48105. E-mail cornicj@aa.wl.com.

The action of an -6 lipoxygenase (LO) has been implicated in the development of atherosclerosis through a mechanism involving oxidation of LDL, and its regulation in macrophages may have important implications for the disease process. Human monocyte–derived macrophages (HMDMs) showed no demonstrable LO protein or activity unless they were incubated with interleukin-4 (IL-4). In contrast, mouse peritoneal macrophages (MPMs) possessed significant basal levels of LO activity and protein that were augmented by IL-4 treatment. Interferon gamma prevented the induction of LO in both HMDMs and MPMs. Whereas interferon gamma could completely block the IL-4 induction of LO in human cells, it did not suppress basal LO activity in MPMs. Both HMDMs and MPMs exhibited similar concentration-response relationships for stimulation of LO activity and protein, with maximal induction at 1 ng/mL IL-4. The time course of IL-4 induction of LO activity was markedly different in human and murine cells. IL-4 induced LO activity and protein in human cells by 48 hours that were maximal by 72 hours; there was a decline to a new baseline by 96 hours. MPMs have a significant amount of LO activity at baseline, which declined with time by nearly 10-fold in the absence of IL-4. IL-4 blunted the decline of LO activity with time and restored activity to that found at baseline by 48 hours. IL-4 was not responsible for the LO activity present in freshly isolated MPMs since both activity and protein content were similar in cells harvested from IL-4^+/+ and IL-4^-/- mice. Therefore, whereas IL-4 may be an important modulator of LO production in vitro, it is not essential for the in vivo expression of this protein. Further, these studies demonstrate that significant differences exist between monocyte-derived macrophages matured in vitro and tissue macrophages that have matured in vivo.

Key Words: interleukin-4 • lipoxygenase • macrophage • regulation

This article has been cited by other articles:

				Y. Huo, L. Zhao, M. C. Hyman, P. Shashkin, B. L. Harry, T. Burcin, S. B. Forlow, M. A. Stark, D. F. Smith, S. Clarke, et al. Critical Role of Macrophage 12/15-Lipoxygenase for Atherosclerosis in Apolipoprotein E-Deficient Mice Circulation, October 5, 2004; 110(14): 2024 - 2031. [Abstract] [Full Text] [PDF]

				B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF]

				J. A. Cornicelli, D. Butteiger, D. L. Rateri, K. Welch, and A. Daugherty Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages J. Lipid Res., March 1, 2000; 41(3): 376 - 383. [Abstract] [Full Text]

				K. Schnurr, A. Borchert, and H. Kuhn Inverse regulation of lipid-peroxidizing and hydroperoxyl lipid-reducing enzymes by interleukins 4 and 13 FASEB J, January 1, 1999; 13(1): 143 - 154. [Abstract] [Full Text]

				B. Roy and M. K. Cathcart Induction of 15-Lipoxygenase Expression by IL-13 Requires Tyrosine Phosphorylation of Jak2 and Tyk2 in Human Monocytes J. Biol. Chem., November 27, 1998; 273(48): 32023 - 32029. [Abstract] [Full Text] [PDF]

				D. Heydeck, L. Thomas, K. Schnurr, F. Trebus, W. E. Thierfelder, J. N. Ihle, and H. Kuhn Interleukin-4 and -13 Induce Upregulation of the Murine Macrophage 12/15-Lipoxygenase Activity: Evidence for the Involvement of Transcription Factor STAT6 Blood, October 1, 1998; 92(7): 2503 - 2510. [Abstract] [Full Text] [PDF]

				S. M. Sendobry, J. A. Cornicelli, K. Welch, M. J. Grusby, and A. Daugherty Absence of T Lymphocyte-Derived Cytokines Fails to Diminish Macrophage 12/15-Lipoxygenase Expression In Vivo J. Immunol., August 1, 1998; 161(3): 1477 - 1482. [Abstract] [Full Text] [PDF]

				K. J. Scheidegger, S. Butler, and J. L. Witztum Angiotensin II Increases Macrophage-mediated Modification of Low Density Lipoprotein via a Lipoxygenase-dependent Pathway J. Biol. Chem., August 22, 1997; 272(34): 21609 - 21615. [Abstract] [Full Text] [PDF]